Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $4.94 and last traded at $4.97, with a volume of 2844941 shares trading hands. The stock had previously closed at $5.21.
Wall Street Analysts Forecast Growth
Separately, Bank of America upgraded shares of Bayer Aktiengesellschaft from an "underperform" rating to a "neutral" rating in a report on Friday, September 6th. One research analyst has rated the stock with a sell rating and six have given a hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold".
Check Out Our Latest Report on Bayer Aktiengesellschaft
Bayer Aktiengesellschaft Stock Performance
The firm's 50-day simple moving average is $6.95 and its two-hundred day simple moving average is $7.27. The company has a debt-to-equity ratio of 1.04, a quick ratio of 0.86 and a current ratio of 1.27.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by ($0.10). Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.46%. The business had revenue of $10.96 billion during the quarter. As a group, equities analysts expect that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.
Bayer Aktiengesellschaft Company Profile
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
See Also
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
